These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1485 related articles for article (PubMed ID: 21219188)

  • 21. Deregulated inflammasome signaling in disease.
    Lamkanfi M; Vande Walle L; Kanneganti TD
    Immunol Rev; 2011 Sep; 243(1):163-73. PubMed ID: 21884175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NLRP3 inflammasome in cancer and metabolic diseases.
    Sharma BR; Kanneganti TD
    Nat Immunol; 2021 May; 22(5):550-559. PubMed ID: 33707781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NLRP3 Inflammasome and Caspase-1/11 Pathway Orchestrate Different Outcomes in the Host Protection Against
    Paroli AF; Gonzalez PV; Díaz-Luján C; Onofrio LI; Arocena A; Cano RC; Carrera-Silva EA; Gea S
    Front Immunol; 2018; 9():913. PubMed ID: 29774028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NLRC3 protein inhibits inflammation by disrupting NALP3 inflammasome assembly via competition with the adaptor protein ASC for pro-caspase-1 binding.
    Eren E; Berber M; Özören N
    J Biol Chem; 2017 Jul; 292(30):12691-12701. PubMed ID: 28584053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammasomes and rheumatic diseases: evolving concepts.
    Sidiropoulos PI; Goulielmos G; Voloudakis GK; Petraki E; Boumpas DT
    Ann Rheum Dis; 2008 Oct; 67(10):1382-9. PubMed ID: 17921182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional regulation of inflammasome-associated pattern recognition receptors, and the relevance to disease pathogenesis.
    Deswaerte V; Ruwanpura SM; Jenkins BJ
    Mol Immunol; 2017 Jun; 86():3-9. PubMed ID: 27697299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammasome activation in obesity-related inflammatory diseases and autoimmunity.
    Lukens JR; Dixit VD; Kanneganti TD
    Discov Med; 2011 Jul; 12(62):65-74. PubMed ID: 21794210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages.
    Khare S; Dorfleutner A; Bryan NB; Yun C; Radian AD; de Almeida L; Rojanasakul Y; Stehlik C
    Immunity; 2012 Mar; 36(3):464-76. PubMed ID: 22361007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. β-arrestin1 is critical for the full activation of NLRP3 and NLRC4 inflammasomes.
    Mao K; Chen S; Wang Y; Zeng Y; Ma Y; Hu Y; Zhang H; Sun S; Wu X; Meng G; Pei G; Sun B
    J Immunol; 2015 Feb; 194(4):1867-73. PubMed ID: 25582856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NLRP3 inflammasome activation triggers gasdermin D-independent inflammation.
    Wang C; Yang T; Xiao J; Xu C; Alippe Y; Sun K; Kanneganti TD; Monahan JB; Abu-Amer Y; Lieberman J; Mbalaviele G
    Sci Immunol; 2021 Oct; 6(64):eabj3859. PubMed ID: 34678046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Focus on negatively regulated NLRs in inflammation and cancer.
    Wang J; He W; Li C; Ma Y; Liu M; Ye J; Sun L; Su J; Zhou L
    Int Immunopharmacol; 2024 Jul; 136():112347. PubMed ID: 38820966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The inflammasome: Learning from bacterial evasion strategies.
    Shin S; Brodsky IE
    Semin Immunol; 2015 Mar; 27(2):102-10. PubMed ID: 25914126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammasomes.
    de Zoete MR; Palm NW; Zhu S; Flavell RA
    Cold Spring Harb Perspect Biol; 2014 Oct; 6(12):a016287. PubMed ID: 25324215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of inflammasomes in dendritic cells and macrophages by Mycoplasma salivarium.
    Sugiyama M; Saeki A; Hasebe A; Kamesaki R; Yoshida Y; Kitagawa Y; Suzuki T; Shibata K
    Mol Oral Microbiol; 2016 Jun; 31(3):259-69. PubMed ID: 26177301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IRAK-1 bypasses priming and directly links TLRs to rapid NLRP3 inflammasome activation.
    Lin KM; Hu W; Troutman TD; Jennings M; Brewer T; Li X; Nanda S; Cohen P; Thomas JA; Pasare C
    Proc Natl Acad Sci U S A; 2014 Jan; 111(2):775-80. PubMed ID: 24379360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The nucleotide-binding domain and leucine-rich repeat protein-3 inflammasome is not activated in airway smooth muscle upon toll-like receptor-2 ligation.
    Hirota JA; Im H; Rahman MM; Rumzhum NN; Manetsch M; Pascoe CD; Bunge K; Alkhouri H; Oliver BG; Ammit AJ
    Am J Respir Cell Mol Biol; 2013 Oct; 49(4):517-24. PubMed ID: 23614732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutting edge: NLRC5-dependent activation of the inflammasome.
    Davis BK; Roberts RA; Huang MT; Willingham SB; Conti BJ; Brickey WJ; Barker BR; Kwan M; Taxman DJ; Accavitti-Loper MA; Duncan JA; Ting JP
    J Immunol; 2011 Feb; 186(3):1333-7. PubMed ID: 21191067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of the NLRP3 inflammasome and elevation of interleukin-1β secretion in infection by sever fever with thrombocytopenia syndrome virus.
    Li Z; Hu J; Bao C; Gao C; Zhang N; Cardona CJ; Xing Z
    Sci Rep; 2022 Feb; 12(1):2573. PubMed ID: 35173184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exogenous nanoparticles and endogenous crystalline molecules as danger signals for the NLRP3 inflammasomes.
    Shirasuna K; Karasawa T; Takahashi M
    J Cell Physiol; 2019 May; 234(5):5436-5450. PubMed ID: 30370619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in Nod-like receptors (NLR) biology.
    Barbé F; Douglas T; Saleh M
    Cytokine Growth Factor Rev; 2014 Dec; 25(6):681-97. PubMed ID: 25070125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 75.